- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Is "pelvic radiation disease" always the cause of bowel symptoms following prostate cancer intensity-modulated radiotherapy? - Abstract
February 11, 2014
Activity of cabazitaxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents - Abstract
February 10, 2014
Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer - Abstract
February 10, 2014
On the sensitivity of α/β prediction to dose calculation methodology in prostate brachytherapy - Abstract
February 10, 2014
The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period - Abstract
February 10, 2014
Target ablation-Image-guided therapy in prostate cancer - Abstract
February 10, 2014
Bone metastases treated with radiopharmaceuticals - Abstract
February 7, 2014
Challenges and Recommendations for Early Identification of Metastatic Disease in Prostate Cancer - Abstract
February 7, 2014
Luteinizing hormone-releasing hormone antagonists for urinary obstruction in prostate cancer - Abstract
February 7, 2014
Change in prostate volume during extreme hypo-fractionation analysed with MRI - Abstract
February 7, 2014
A prostate biopsy strategy based on a new clinical nomogram reduces the number of biopsy cores required in high-risk patients - Abstract
February 7, 2014
Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium - Abstract
February 7, 2014
Quantifying the combined effect of radiation therapy and hyperthermia in terms of equivalent dose distributions - Abstract
February 7, 2014
The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients - Abstract
February 7, 2014